A dynamic network of startups coming out of McMaster University — along with an eye- popping takeover of a homegrown success story — is fuelling Hamilton’s rise as a national biotech capital.
Triumvira Immunologics Inc., a Hamilton biotech firm started at McMaster University, is developing a next-generation immunotherapy treatment to tackle solid-cell cancers.
The day-long event outlined the journey from academic discovery to commercial development, highlighting recent startup successes at McMaster